SlideShare a Scribd company logo
1 of 75
EndocarditisEndocarditis
EpidemiologyEpidemiology
An estimated 10,000 to 15,000 new cases of infective endocarditis
(IE) are diagnosed in the United States each year.
Men predominate in most case series, with male-to-female ratios
ranging from 2:1 to 9:1.
The importance of underlying heart disease in children with IE varies
with age: 50 to 70 percent of children less than 2 years old have no
obvious underlying cardiac disease , while most older children have
coexistent congenital heart disease.
A number of factors predispose to the development of infective
endocarditis. These include IVDA, prosthetic heart valves, and
structural heart disease.
Newer trends show endocarditis has increasingly become a disease
of the elderly. This trend is probably due to the decline in the
incidence and importance of rheumatic heart disease as a risk factor
for IE and the increasing proportion of elderly subjects in the
general population.
Also the proportion of cases that present with an indolent course
and the proportion due to streptococci has declined recently, while
simultaneous increases have occurred in the proportion of cases due
to Staphylococcus aureus, fungi, and gram negative bacilli.
The rising incidence of injection drug use (IVDA) has had an
impact on the overall incidence of endocarditis, as well as it’s
geographic distribution. Drug addiction as a cause of IE is most
prominent in patients less than 40 years old.
Intravenous Drug Abuse (IVDA)Intravenous Drug Abuse (IVDA)
In addition to the injection itself, specific drugs of abuse may also
be risk factors for the development of endocarditis which often
involves the right side of the heart. One large study found that those
who used cocaine were significantly more likely to have
endocarditis than those using other drugs. Ann Int Med 1987. 106:833.
The most significant risk factor for right-sided IE is IVDA;
however, left-sided disease may be more common in addicts.
The most common infecting organism is S. aureus, particularly in
right-sided infection with prevalence up to 82 percent. The
vegetations are usually > or =1 cm in diameter, and there is a
marked increase in mortality associated with vegetations greater
than 2 cm (33 versus 1.3 percent for smaller vegetations). Ann Int Med 1992.
117;560.
Prosthetic Heart ValveProsthetic Heart Valve
Prosthetic valve endocarditis develops in 1 to 4 percent of valve
recipients during the first year following valve replacement, and in
approximately 0.5-1 percent per year thereafter.
The type of prosthetic valve (bio vs mech) does not have an impact
on the development of IE.
Structural Heart DiseaseStructural Heart Disease
Approximately 3/4 of all patients with IE have a preexisting
structural cardiac abnormality at the time that endocarditis begins.
The risk of IE in patients with mitral valve prolapse and associated
regurgitation is estimated to be 5 to 8 times higher than that in the
normal population. However, MVP without MR is a more common
abnormality that is associated with only a small risk of endocarditis.
NEJM 1982. 307;776.
The most common predisposing congenital heart lesions are
bicuspid aortic valves, patent ductus arteriosus, ventricular septal
defect, coarctation of the aorta, and tetralogy of Fallot.
Prevalence of rheumatic valve disease is on the decline.
The risk of IE appears to be dependent upon the specific congenital
or acquired cardiac lesion. One study, for example, evaluated 2401
patients with congenital heart lesions who were followed
prospectively for 40,000 days. Circulation 1993. 87; 121
• The overall incidence of endocarditis was 135 cases/100,000
person years.
• The highest rates of endocarditis occurred in patients with aortic
stenosis (271)and ventricular septal defects (145 cases/100,000
person yrs).
•Among patients with AS, the higher the peak gradient, the higher
the risk of developing endocarditis.
• The risk of IE with AS was approximately twice as high as with
aortic regurgitation.
• The lowest rate of endocarditis occurred with pulmonic stenosis.
•The risk of IE also appears to be very low in adults with congenital
heart disease, inherently normal pulmonic and tricuspid valves, and
pulmonary or tricuspid regurgitation due to pulmonary hypertension.
Other Risk factorsOther Risk factors
A prior history of endocarditis is an important predisposing cause for
IE. Recurrent endocarditis occurred in 4.5 percent of one large cohort
of non-addicts who survived their initial episode. Ann Int Med 1992 117;567.
A number of cases of IE have been reported in patients with HIV
infection with some valves have been infected with unusual
organisms such as Salmonella and Listeria. It has been suggested that
HIV infection is an independent risk factor for IE in injection drug
abusers but, this has not been confirmed in other reports.
Other less common predisposing factors for IE are pregnancy,
arteriovenous fistulas used for hemodialysis, central venous and
pulmonary artery catheters, peritoneovenous shunts for the control of
intractable ascites and ventriculoatrial shunts for the management of
hydrocephalus.
Patients with ulcerative lesions of the colon due to carcinoma or
inflammatory bowel disease have a poorly understood predilection
to develop endocarditis secondary to Streptococcus bovis.
IE has also been reported in patients undergoing liver, heart, and
heart-lung transplantation.
PathogenesisPathogenesis
The endothelial lining of the heart and its valves is normally
resistant to infection with bacteria and fungi.
Although a few highly virulent organisms such as Staphylococcus
aureus are capable of infecting normal human heart valves, the
initial step in the establishment of a vegetation is injury to the
endocardium, followed by focal adherence of platelets and fibrin.
These injuries can probably occur naturally in bacteremic humans
with congenital or acquired cardiac lesions that induce continuous
endocardial trauma via regurgitant flow or high pressure jets of
blood through stenotic lesions.
The initially sterile platelet-fibrin nidus then becomes infected by
microorganisms circulating in the bloodstream, following
colonization then microbial growth results in the secondary
accumulation of more platelets and fibrin.
Microbial adherence is a crucial early event in the pathogenesis of
endocarditis. As an example, bacteria that are typically found in
patients with endocarditis, such as Staphylococcus aureus, viridans
streptococci, enterococci and P. aeruginosa, adhere more avidly to
excised canine heart valves in vitro than species which rarely cause
endocarditis (such as Escherichia coli).
Dextran in the cell wall of gram positive organisms is one factor.
Degree of intrinsic binding affinity to fibronectin is important in the
virulence of S. aureus species.
Components found in damaged endothelium and/or platelet-fibrin
aggregates that may mediate adherence include fibrinogen, laminin,
and type 4 collagen.
Animals treated with aspirin had reduction in the weight of valvular
vegetations, vegetation growth, density of bacteria in the kidneys and
in vegetations, and a decrease in embolic events compared to
controls.
This interference with platelet-fibrin aggregates suggests that
addition of low dose aspirin can reduce risk of embolization during
antibiotic treatment, or risk of IE recurrence.
A small clinical study of 9 pts suggested ASA to be protective.
J Int Med 1992; 231:543
However a more recent randomized trial showed despite promising
experimental data, there was no clinical benefit to ASA.
115 pts in Can&US were doubly blinded to receive ASA or placebo.
Followed for 4wks for primary outcome of clinical embolism,
secondary outcome of CT shown subclinical CVA, hemorrhage or
death.
No sig difference in embolization. (ASA 28% vs placebo 20%)
Non-sig trend for combined major&minor hemorrhage in ASA grp.
Total of 70% had CT head done, with significant lesions in 39.5%
ASA group vs 29.3% in placebo.
Total of 42% had TEE, which showed similar rate of vegetation
decrease or valvular regurgitation.
JACC 2003; 42:775
Physics of VegetationsPhysics of Vegetations
If nebulized Serratia marcescens, are injected into an air stream passing through an
agar-coated Venturi tube, the highest concentration of bacteria is found in the low
pressure area immediately distal to the narrowing. Circulation 1963. 27;18
Vegetations in patients with preexisting valvular lesions are usually located on the
atrial surface of incompetent atrioventricular valves, or the ventricular surfaces of
incompetent semilunar valves.
Patients with ventricular septal defects tend to develop vegetations on the orifice of
the defect, on the right ventricular side of the opening, and secondarily on the
tricuspid and pulmonic valves.
Vegetations may occasionally localize on the chordae tendineae of the anterior
leaflet of the mitral valve in patients with aortic insufficiency.
Patients with mitral regurgitation may develop vegetations (MacCallum's patch) on
the wall of the left atrium where the regurgitant jet strikes the atrial wall and results
in endocardial thickening.
Clinical SequelaeClinical Sequelae
Vegetations often prevent proper valvular leaflet or cusp coaptation, thereby
causing valvular incompetence.
Congestive heart failure may result from worsening valvular incompetence or
leaflet perforation secondary to vegetation growth.
Patients with mitral or tricuspid valve vegetations may develop chordal rupture.
Infection may also extend into surrounding structures such as the valve ring, the
adjacent myocardium, the cardiac conduction system, or the mitral-aortic
intravalvular fibrosa.
Rarely, cavitation of periaortic abscesses occurs into the adjacent aortic wall,
resulting in the formation of a diverticulum or aneurysm.
Even more rarely, such aneurysms perforate into surrounding structures, resulting
in aortic-atrial or aortic-pericardial fistulae.
Etiology (Native Valve)Etiology (Native Valve)
Although any bacteria can cause IE, Streptococci, Enterococci and
Staphylococci account for the majority of the cases.
Streptococci
Streptococci account for about 55% of non-IVDA cases.
Viridans streptococci account for ~75% of these cases.
Most common of the group are Streptococcus mutans, S.
mitis, S. Milleri.
S. Bovis account for ~20%.
Other Streptococci are ~5%.
Viridans strep are normal pharynx inhabitants and are generally very
susceptible to PCN.
80% of S. Bovis cases occurs in elderly (>60yrs). More than a third
have a malignant or pre-malignant colonic lesion.
Enterococci
Cause about 6% of native valve endocarditis and are normal flora of
GI tract, anterior urethra and occasionally the mouth.
They are relatively resistant to PCN-G and require the addition of
an aminoglycoside to achieve bactericidal effect.
More common among males who develop infection around 60 yrs of
age.
Many have history of GU tract manipulation, trauma or disease.
Cystoscopy, Foley catheter, prostatectomy.
Caesarian section, abortion, pregnancy.
Staphylococci
Staph cause about 30% of native valve IE cases, with S. aureus
being 5 to 10 times more frequent than S. epidermidis.
S. Aureus can rapidly attack normal or damaged valves.
It has a fulminant course with death from bacteremia within
days, or from heart failure within weeks.
Abscesses are common at multiple sites.
S. Epidermidis usually infects prosthetic valves.
HACEK organisms
Haemophilus
Actinobacillus
Cardiobacterium
Eikenella
Kingella
They are part of the oropharyngeal flora and produce large
vegetations with a subacute presentation.
They are difficult to isolate from blood and grow slowly in blood
culture media. Incubation for 7 to 14 days may be required to detect
their growth. This delayed growth makes standard antibiotic
susceptibility testing difficult.
Other Bacteria
Almost any bacteria can be an occasional cause of acute or subacute
endocarditis.
Streptococcus pneumoniae
Neisseria gonorrhoeae
Enteric gram –ve bacilli
Pseudomonas
Salmonella
Streptobacillus
Serratia marcescens
Bacteroides
Brucella
Mycobacterium
Neisseria meningitidis
Listeria
Legionella
Corynebacterium
Fungi
Rarely cause native valve IE. Subacute course with large
vegetations and large emboli.
Candida and Aspergillus species can occur in persons with
intravascular catheters who are frequently on glucocorticoids,
broad spectrum Abx, cytotoxic drugs.
Grave prognosis due to the relatively poor activity of antifungal;
agents.
Other Organisms
Rare causes can include Spirochetes, Rickettsiae (Coxiella burnetti),
Chlamydiae (C. pneumoniae, C. trachomatis, C. psittaci).
Etiology (IVDA)Etiology (IVDA)
Frequently occurs in young males with the skin being the most common source of
organisms. Contamination of drugs is less common.
More than 50% is by S. aureus.
~20% by Streptococci and Enterococci.
~6% Fungi, mainly candida.
~6% gram –ve bacilli, usually Pseudomonas species.
Onset is usually acute, with only 20% of addicts having previously damaged
valves.
Half the cases are involving the tricuspid valve. Aorta is involved in 25% of cases.
Mitral valve is involved 20% of the time. Multiple valves less than 5%.
In TV endocarditis, murmurs are usually absent and pneumoniae from septic
emboli is frequently the presenting picture.
Etiology (Prosthetic Valve)Etiology (Prosthetic Valve)
With the aging population, prosthetic valve endocarditis now
accounts for 10 to 20% of cases.
Intravascular sutures, pacemaker wires and Teflon-Silastic tubes are
all foci for infection.
Most patients are males over 60 and IE occurs in 1-2% in the first
year after surgery , and 0.5% a year thereafter.
AV prosthesis are more likely to be involved than MV, and infection
is usually at the suture line.
Early onset (within 60days) is usually as a result of valve
contamination or peri-operative bacteremia.
Almost half of early onset, and third of late onset endocarditis are
due to Staphylococci. S. epidermidis is more frequently involved
than S. aureus.
Streptococci are the most common cause (40%) of late onset
endocarditis, but are rare in early onset.
Clinical ManifestationsClinical Manifestations
Symptoms generally start within two weeks of precipitating event.
With low pathogenicity organism (ie viridans)the onset is usually
slow with low fevers. With fulminant disease (ie S. aureus) the onset
is rapid with high fevers.
Fever is almost always present. Arthralgias, myalgias and low back
pain are common.
Cardiac murmurs are almost always present, except in acute early IE
and in IVDA with TV lesions.
Splenomegaly and petechia are usually found in disease of long
duration.
Petechiae are more common on conjunctiva, palate, buccal mucosa
and upper extremities.
Splinter hemorrhages are subungual, linear dark red streaks that may
appear in IE, but can also result from trauma.
Roth’s spots are oval retinal hemorrhages with a clear pale center. But
it can occur in connective tissue diseases and sever anemia.
Osler’s nodes are small tender nodules in the pads of fingers and toes.
Janeway’s lesions are small circular hemorrhagic lesions, that are
nodular and occur on palms and soles of feet.
Clubbing has been reported in patients with long standing disease.
Embolic episodes can occur during or after therapy. Large emboli are
generaly fungal.
Neurologic manifestations are more common in left sided disease,
and in S. aureus infection.
Heart failure can occur long after it’s cure. Causes include valvular
damage, myocarditis, abscess formation and coronary artery
embolization with infarction.
Conduction defects occur due to septal invasion.
Renal disease exists in most patients due to renal emboli, or immune
complex mediated glomerulonephritis.
Diagnostic WorkupDiagnostic Workup
At least three blood cultures should be obtained from separate sites
over a time period ranging from a few hours to one to two days
depending upon the severity of illness and urgency of the need for
treatment.
The additional diagnostic yield of more than three cultures is minimal
in patients who have not recently received antimicrobial therapy.
A TTE should initially be obtained in patients with native heart
valves, while those with prosthetic valves should undergo TEE.
Detection of a vegetation is a positive test. However, this procedure
has relatively low sensitivity in IE. Thus, a negative study does not
preclude the diagnosis
TTE should be followed by TEE, which has higher spatial
resolution, when there is an intermediate or high suspicion of IE
and valvular abnormalities were found on TTE.
In general the sensitivity of TTE in detecting vegetations is ~65-
80%. The addition of TEE increases the sensitivity to 95%.
In prosthetic valves TTE is has poor diagnostic value. However,
TEE carries a 90% sensitivity in this setting.
JACC 1991;18
A meticulous clinical examination should be performed looking for
clinical evidence of small and large emboli with special attention to
the fundi, conjunctivae, skin, and digits.
In addition, a careful cardiac examination may reveal signs of new
regurgitant murmurs and signs of congestive heart failure, and
neurologic evaluation may detect evidence of focal neurologic
impairment and can be used to document a baseline should such
abnormalities appear later.
Additional clues to the presence of IE, such as microscopic
hematuria, leukocytosis, and evidence of renal impairment should
be sought with laboratory testing.
All patients with suspected IE should have an electrocardiogram to
determine whether there is evidence of heart block or a conduction
delay and to establish a baseline should such a complication
develop later.
Echo SamplesEcho Samples
Duke ClassificationDuke Classification
In 1994 investigators from Duke University modified the von Reyn
criteria to include the role of echocardiography in diagnosis. They
also expanded the category of predisposing heart conditions to
include injection drug use.
This was later modified further to include the role of TEE as well as
the agent of Q fever (Coxiella brunetti).
The Duke classification relies upon major and minor criteria in a
manner similar to the Jones criteria for rheumatic fever.
Major Criteria
•Isolation of causative organism by two separate blood culture’s at
least 12hrs apart.
•Endocardial involvement evidence by echo. Oscillating mass,
prosthetic valve dehiscence, abscess, new regurgitation.
Minor criteria
•Predisposing lesion or IVDA
•Fever >38C
•Signs of embolization: Janeway lesion, Intracran hem.
•Immunologic phenomena: Glomerulonephritis, Oslers nodes,
Rheumatoid factor, Roths spots.
•Positive blood culture not meeting major criteria.
•Echo finding, but not meeting major criteria.
Modified Duke Criteria
Definite Infective Endocarditis
Pathologic criteria:
Microorganisms demonstrated by culture or histology in a
vegetation or embolus.
Clinical criteria:
2 major or
1 major + 3 minor or
5 minor
Possible endocarditis
Findings that are suggestive of IE but fall short of definite, but not rejected.
Rejected Infective Endocarditis
Alternate diagnosis explaining evidence of endocarditis
Resolution of syndrome with antibiotic therapy in 4 days or less.
No pathologic evidence at surgery with Abx therapy of four days or less.
Clin Inf Dis 2000;30
Treatment RegimensTreatment Regimens
In general the antibiotic regimen chosen is based on agent isolated.
The initial microbiologic response to therapy should be assessed by
obtaining repeat blood cultures 48 to 72 hours after antibiotics are
begun.
Most patients with IE generally become afebrile three to five days
after treatment is begun with an appropriate antibiotic. Patients with
Staphylococcal aureus endocarditis may respond somewhat more
slowly, remaining febrile for five to seven days after the institution of
therapy.
In general, oral regimens should not be used as initial therapy, but
may be used in highly selected cases. In right-sided endocarditis of
IVDA combination oral therapy with rifampin and ciprofloxacin was
as effective as parenteral therapy in patients in whom oral therapy
could be closely supervised. Am J Med 1996.101;68
Treatment regimen summary
Native valve
Strep Viridans or Strep Bovis -PCN sensitive
PCN-G or Ceftriaxone 4wks
If allergic, Vancomycin 4wks
Strep Viridans or Strep Bovis - PCN resistant
PCN 4wks+Gent 2wk
Vancomycin 4wks
Enterococcus
PCN/AMP + Gent 6wks
Vanco + Gent 6wks
Staph infection
Cefazolin 6wks +/- Gent 5days
Vanco 6wks
HACEK Organisms
Ceftriaxone 4wks
Prosthetic valve
Streptococcus-PCN sensistive
Ceftriaxone 6wks + Gent 2wks
Vanco 6wks
Streptococcus-PCN resistant Strep
Vanco 6wks
Enterococci
PCN or Amp 6wks + Gent 6wks
Vanco+Gent 6wks
Methicllin Susceptible Staph
Nafcillin 6wks + Gent 2wks + Rifampin 6wks
MRSA
Vanco 8wks + Gent 2wks + rifampin 8wks
HACEK
Ceftriaxone 6wks
Diptheroides
PCN +Gent 6wks
Vanco 6wks
Surgical InterventionSurgical Intervention
The outcome of surgery is better when the infection is partially
treated or healed. So, patients with severe valve dysfunction who
respond to antibiotic therapy and who manifest evidence of only
mild and nonprogressive heart failure should complete a full course
of antibiotics before surgery is undertaken to minimize morbidity
and mortality.
However, surgery should not be delayed to complete antimicrobial
therapy in patients with progressive heart failure or evidence of
other complications.
Two general classes of valves exist, bioprosthetic and mechanical.
Prosthetic ValvesProsthetic Valves
Class I indication for native valve surgery
Acute AR or MR with heart failure
Acute AR with tachycardia or early closure or MV on echo
Fungal endocarditis
Aortic or annular abscess, or aortic aneurysm
Valve dysfunction or infection after 10 days of Abx therapy
Class II indication for native valve surgery
Recurrent emboli after >24hrs Abx therapy
Mobile vegetations >10mm
Recommendation for Bioprosthesis placement
Pt cannot take warfarin
>65yrs who do not need warfarin for another cause
Recommendation for mechanical valve placement
Expected long life span
Mechanical valve in another position
Pt with renal failure or hypercalcemia
Require warfarin for another cause
Non-bacterial ThromboticNon-bacterial Thrombotic
EndocarditisEndocarditis
Combination of endothelial injury and hypercoagulable state can
lead to platelet-thrombin deposition.
These deposits are found on the atrial side of MV & TV, and the
ventricular side of AV & PV; similar to location of infective
vegetations.
Most common associated syndrome with this condition is the anti-
phospholipid syndrome.
The atypical verroucous Libman-Sacks vegetations are usually
difficult to see on TTE.
They usually accumulate on the distal tip of the MV.
Metastatic tumours can also involve cardiac valves and produce
lesions similar to IE.
These marantic endocarditis lesions occur more frequently in
Hodgkin and adenocarcinoma of the lung, stomach and colon.
All non bacterial thrombotic lesion can become infected if exposed
to bacteremia.
Antibiotic ProphylaxisAntibiotic Prophylaxis
Bacteria colonize and adhere to platelet-fibrin aggregates during
bacteremia.
Although many bacteria enter the blood stream, only those suited to
adhere to surfaces can become infective.
Certain predisposing valvular lesions are also required to increase
your risk of colonization.
This has led to identifying patients at risk during surgical
procedures and the use of prophylactic antibiotics.
Prophylaxis recommended
Dental procedures, including scaling and cleaning
Tonsillectomy & adenoidectomy
Surgery involving GI or upper respiratory mucosa
Esophageal varices sclerotherapy
ERCP
Cholecystectomy
Cystoscopy, urethral dilatation
GU surgery
Incision and drainage of infected tissue
Prophylaxis not recommended
Dental procedures not likely to produce bleeding, i.e. filling
above gum line, orthodontic adjustments.
Endotracheal intubation
TEE
Flexible bronchoscope +/- biopsy
Angiography +/- PTCA
Pacemaker implantation
GI Endoscopy +/- biopsy
C-section
In absence of infection: uncomplicated vaginal delivery,
therapeutic abortion, IUD, laparoscopy, circumcision.
High Risk Patients
Prosthetic valve
Prior IE
Cyanotic congenital heart disease
PDA
AR
AS
MR
MS + MR
VSD
Coarctation of Ao
Surgically constructed systemic-pulmonary shunts
Surgically corrected cardiac lesion with residual hemodynamic
abn or prosthesis.
Intermediate Risk Patients
MV prolapse or thickening with murmur
Pure MS
TV disease
PS
Asymmetrical septal hypertrophy
Bicuspid AV with minimal hemodynamic changes
Ao sclerosis with minimal hemodynamic changes
Surgically repaired intracardiac lesions, less than six mos postop,
with minimal hemodynamic changes.
Low Risk Patients
MV prolapse without murmur
Isolated secundum ASD
Implanted devices
CABG
Prior Kawasaki’s or Rheumatic disease without valvular
dysfunction
Antibiotic Prophylaxis SummaryAntibiotic Prophylaxis Summary
GI/GU regimen
High risk Amp 2g & Gent 1.5mg/kg.
Mod risk Amox 2g or Amp.
PCN allergy = Substitute Vanco 1g
Oral/Esoph/Resp regimen
Amox PO or Amp IV
PCN allergy = Substitute Clinda 600mg PO/IV
Cefazolin 1g
Azith/Clarith PO 500mg
Abx should be given prior to procedure, 1hr for oral
1/2hr for parenteral
Questions?Questions?
UTD Abx TablesUTD Abx Tables
UTD Surgery tablesUTD Surgery tables
Epidemiology and Risk Factors of Endocarditis
Epidemiology and Risk Factors of Endocarditis
Epidemiology and Risk Factors of Endocarditis
Epidemiology and Risk Factors of Endocarditis
Epidemiology and Risk Factors of Endocarditis

More Related Content

What's hot

Endocarditis presentation to internal medicine2019
Endocarditis presentation to internal medicine2019Endocarditis presentation to internal medicine2019
Endocarditis presentation to internal medicine2019hospital
 
Infective endocarditis@ghanem@
Infective endocarditis@ghanem@Infective endocarditis@ghanem@
Infective endocarditis@ghanem@Islam Ghanem
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditisKalpana Gogoi
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditisPratik Kumar
 
Infective endocarditis and heart masses
Infective endocarditis and heart massesInfective endocarditis and heart masses
Infective endocarditis and heart massesFuad Farooq
 
Infective endocarditis/ endocarditis
Infective endocarditis/ endocarditisInfective endocarditis/ endocarditis
Infective endocarditis/ endocarditisSundaresanL
 
infective endocarditis- dental applications
infective endocarditis- dental applicationsinfective endocarditis- dental applications
infective endocarditis- dental applicationsSohail Mohammed
 
Infective Endocarditis & Noninfected vagetation presentation
Infective Endocarditis & Noninfected vagetation presentation Infective Endocarditis & Noninfected vagetation presentation
Infective Endocarditis & Noninfected vagetation presentation Tahir Ramzan
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditisstudent
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective EndocarditisDiya Saleh
 
Infective endocarditis(IE) a brief insight- by Rxvichu!!!
Infective endocarditis(IE)  a brief insight- by Rxvichu!!!Infective endocarditis(IE)  a brief insight- by Rxvichu!!!
Infective endocarditis(IE) a brief insight- by Rxvichu!!!RxVichuZ
 
Infective endocarditis 16 4-2016
Infective endocarditis 16 4-2016Infective endocarditis 16 4-2016
Infective endocarditis 16 4-2016pathologydept
 
Infective endocarditis revision notes
Infective endocarditis revision notesInfective endocarditis revision notes
Infective endocarditis revision notesTONY SCARIA
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective EndocarditisDJ CrissCross
 

What's hot (20)

Endocarditis presentation to internal medicine2019
Endocarditis presentation to internal medicine2019Endocarditis presentation to internal medicine2019
Endocarditis presentation to internal medicine2019
 
Infective endocarditis@ghanem@
Infective endocarditis@ghanem@Infective endocarditis@ghanem@
Infective endocarditis@ghanem@
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective endocarditis
Infective endocarditis Infective endocarditis
Infective endocarditis
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective endocarditis and heart masses
Infective endocarditis and heart massesInfective endocarditis and heart masses
Infective endocarditis and heart masses
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Rheuumatic heart disese
Rheuumatic heart diseseRheuumatic heart disese
Rheuumatic heart disese
 
Infective endocarditis/ endocarditis
Infective endocarditis/ endocarditisInfective endocarditis/ endocarditis
Infective endocarditis/ endocarditis
 
infective endocarditis- dental applications
infective endocarditis- dental applicationsinfective endocarditis- dental applications
infective endocarditis- dental applications
 
Infective Endocarditis & Noninfected vagetation presentation
Infective Endocarditis & Noninfected vagetation presentation Infective Endocarditis & Noninfected vagetation presentation
Infective Endocarditis & Noninfected vagetation presentation
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
ENDOCARDITIS
ENDOCARDITIS ENDOCARDITIS
ENDOCARDITIS
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective Endocarditis
 
Infective endocarditis(IE) a brief insight- by Rxvichu!!!
Infective endocarditis(IE)  a brief insight- by Rxvichu!!!Infective endocarditis(IE)  a brief insight- by Rxvichu!!!
Infective endocarditis(IE) a brief insight- by Rxvichu!!!
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective endocarditis 16 4-2016
Infective endocarditis 16 4-2016Infective endocarditis 16 4-2016
Infective endocarditis 16 4-2016
 
Infective endocarditis revision notes
Infective endocarditis revision notesInfective endocarditis revision notes
Infective endocarditis revision notes
 
Endocarditis 2015
Endocarditis  2015Endocarditis  2015
Endocarditis 2015
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective Endocarditis
 

Viewers also liked

Evaluation of prosthetic valve function and clinical utility.
Evaluation of prosthetic valve function and clinical utility.Evaluation of prosthetic valve function and clinical utility.
Evaluation of prosthetic valve function and clinical utility.Ramachandra Barik
 
prosthetic valve replacement
prosthetic valve replacementprosthetic valve replacement
prosthetic valve replacementrahul arora
 
2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD
2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD
2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MDdrabhishekbabbu
 
Eyelid inflammation & tumors
Eyelid inflammation & tumorsEyelid inflammation & tumors
Eyelid inflammation & tumorsHatesh Mahtani
 

Viewers also liked (8)

Mechanical Heart Valves
Mechanical Heart ValvesMechanical Heart Valves
Mechanical Heart Valves
 
Prosthetic Heart Valves
Prosthetic Heart ValvesProsthetic Heart Valves
Prosthetic Heart Valves
 
Evaluation of prosthetic valve function and clinical utility.
Evaluation of prosthetic valve function and clinical utility.Evaluation of prosthetic valve function and clinical utility.
Evaluation of prosthetic valve function and clinical utility.
 
prosthetic valve replacement
prosthetic valve replacementprosthetic valve replacement
prosthetic valve replacement
 
2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD
2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD
2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD
 
Prosthetic heart valves
Prosthetic heart valvesProsthetic heart valves
Prosthetic heart valves
 
Endocarditis 2015
Endocarditis  2015Endocarditis  2015
Endocarditis 2015
 
Eyelid inflammation & tumors
Eyelid inflammation & tumorsEyelid inflammation & tumors
Eyelid inflammation & tumors
 

Similar to Epidemiology and Risk Factors of Endocarditis

Cardiac emergencies in the first year of life
Cardiac emergencies in the first year of lifeCardiac emergencies in the first year of life
Cardiac emergencies in the first year of lifesxbenavides
 
Infective endocarditis.pptx
Infective endocarditis.pptxInfective endocarditis.pptx
Infective endocarditis.pptxaishanteme
 
4_6030689835172236523.pptx
4_6030689835172236523.pptx4_6030689835172236523.pptx
4_6030689835172236523.pptxJibrilAliSe
 
Congenital h.d ..ppt
Congenital h.d ..pptCongenital h.d ..ppt
Congenital h.d ..pptAmritSharma65
 
A case of Marfan syndrome with complications
A case of Marfan syndrome with complicationsA case of Marfan syndrome with complications
A case of Marfan syndrome with complicationsiosrjce
 
Congenital heart diseases
Congenital heart diseasesCongenital heart diseases
Congenital heart diseasesArifa T N
 
Congenital heart diseases
Congenital heart diseasesCongenital heart diseases
Congenital heart diseasesSnehil Agrawal
 
7.congenital heart dss
7.congenital heart dss7.congenital heart dss
7.congenital heart dssWhiteraven68
 
pediatrics congenital heart disease
pediatrics congenital heart diseasepediatrics congenital heart disease
pediatrics congenital heart diseasegetandale zeleke
 
ACYANOTIC DISEASE- Non cyanotic heart diseases
ACYANOTIC DISEASE- Non cyanotic heart diseasesACYANOTIC DISEASE- Non cyanotic heart diseases
ACYANOTIC DISEASE- Non cyanotic heart diseasesNelsonNgulube
 
Infective Endocarditis (IE) Lecture pptx
Infective Endocarditis (IE) Lecture pptxInfective Endocarditis (IE) Lecture pptx
Infective Endocarditis (IE) Lecture pptxShashi Prakash
 
Endocarditis and stroke
Endocarditis and strokeEndocarditis and stroke
Endocarditis and strokeNeurologyKota
 
Atrial fibrillation &stroke feb 2015 ngh
Atrial fibrillation &stroke feb 2015 nghAtrial fibrillation &stroke feb 2015 ngh
Atrial fibrillation &stroke feb 2015 nghasadsoomro1960
 
INFECTIVE ENDOCARDITIS.pptx
INFECTIVE ENDOCARDITIS.pptxINFECTIVE ENDOCARDITIS.pptx
INFECTIVE ENDOCARDITIS.pptxBadarJamal4
 

Similar to Epidemiology and Risk Factors of Endocarditis (20)

Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective Endocarditis
 
Eao lancet
Eao lancetEao lancet
Eao lancet
 
Cardiac emergencies in the first year of life
Cardiac emergencies in the first year of lifeCardiac emergencies in the first year of life
Cardiac emergencies in the first year of life
 
Infective endocarditis.pptx
Infective endocarditis.pptxInfective endocarditis.pptx
Infective endocarditis.pptx
 
4_6030689835172236523.pptx
4_6030689835172236523.pptx4_6030689835172236523.pptx
4_6030689835172236523.pptx
 
Congenital h.d ..ppt
Congenital h.d ..pptCongenital h.d ..ppt
Congenital h.d ..ppt
 
A case of Marfan syndrome with complications
A case of Marfan syndrome with complicationsA case of Marfan syndrome with complications
A case of Marfan syndrome with complications
 
Congenital heart diseases
Congenital heart diseasesCongenital heart diseases
Congenital heart diseases
 
Congenital heart diseases
Congenital heart diseasesCongenital heart diseases
Congenital heart diseases
 
7.congenital heart dss
7.congenital heart dss7.congenital heart dss
7.congenital heart dss
 
pediatrics congenital heart disease
pediatrics congenital heart diseasepediatrics congenital heart disease
pediatrics congenital heart disease
 
Vsd aha 2006
Vsd   aha 2006Vsd   aha 2006
Vsd aha 2006
 
ACYANOTIC DISEASE- Non cyanotic heart diseases
ACYANOTIC DISEASE- Non cyanotic heart diseasesACYANOTIC DISEASE- Non cyanotic heart diseases
ACYANOTIC DISEASE- Non cyanotic heart diseases
 
Infective Endocarditis (IE) Lecture pptx
Infective Endocarditis (IE) Lecture pptxInfective Endocarditis (IE) Lecture pptx
Infective Endocarditis (IE) Lecture pptx
 
AVSD.pptx
AVSD.pptxAVSD.pptx
AVSD.pptx
 
Nature ei
Nature   eiNature   ei
Nature ei
 
Acyanotic heart diseases
Acyanotic heart diseasesAcyanotic heart diseases
Acyanotic heart diseases
 
Endocarditis and stroke
Endocarditis and strokeEndocarditis and stroke
Endocarditis and stroke
 
Atrial fibrillation &stroke feb 2015 ngh
Atrial fibrillation &stroke feb 2015 nghAtrial fibrillation &stroke feb 2015 ngh
Atrial fibrillation &stroke feb 2015 ngh
 
INFECTIVE ENDOCARDITIS.pptx
INFECTIVE ENDOCARDITIS.pptxINFECTIVE ENDOCARDITIS.pptx
INFECTIVE ENDOCARDITIS.pptx
 

Epidemiology and Risk Factors of Endocarditis

  • 2. EpidemiologyEpidemiology An estimated 10,000 to 15,000 new cases of infective endocarditis (IE) are diagnosed in the United States each year. Men predominate in most case series, with male-to-female ratios ranging from 2:1 to 9:1. The importance of underlying heart disease in children with IE varies with age: 50 to 70 percent of children less than 2 years old have no obvious underlying cardiac disease , while most older children have coexistent congenital heart disease. A number of factors predispose to the development of infective endocarditis. These include IVDA, prosthetic heart valves, and structural heart disease.
  • 3. Newer trends show endocarditis has increasingly become a disease of the elderly. This trend is probably due to the decline in the incidence and importance of rheumatic heart disease as a risk factor for IE and the increasing proportion of elderly subjects in the general population. Also the proportion of cases that present with an indolent course and the proportion due to streptococci has declined recently, while simultaneous increases have occurred in the proportion of cases due to Staphylococcus aureus, fungi, and gram negative bacilli. The rising incidence of injection drug use (IVDA) has had an impact on the overall incidence of endocarditis, as well as it’s geographic distribution. Drug addiction as a cause of IE is most prominent in patients less than 40 years old.
  • 4. Intravenous Drug Abuse (IVDA)Intravenous Drug Abuse (IVDA) In addition to the injection itself, specific drugs of abuse may also be risk factors for the development of endocarditis which often involves the right side of the heart. One large study found that those who used cocaine were significantly more likely to have endocarditis than those using other drugs. Ann Int Med 1987. 106:833. The most significant risk factor for right-sided IE is IVDA; however, left-sided disease may be more common in addicts. The most common infecting organism is S. aureus, particularly in right-sided infection with prevalence up to 82 percent. The vegetations are usually > or =1 cm in diameter, and there is a marked increase in mortality associated with vegetations greater than 2 cm (33 versus 1.3 percent for smaller vegetations). Ann Int Med 1992. 117;560.
  • 5. Prosthetic Heart ValveProsthetic Heart Valve Prosthetic valve endocarditis develops in 1 to 4 percent of valve recipients during the first year following valve replacement, and in approximately 0.5-1 percent per year thereafter. The type of prosthetic valve (bio vs mech) does not have an impact on the development of IE.
  • 6. Structural Heart DiseaseStructural Heart Disease Approximately 3/4 of all patients with IE have a preexisting structural cardiac abnormality at the time that endocarditis begins. The risk of IE in patients with mitral valve prolapse and associated regurgitation is estimated to be 5 to 8 times higher than that in the normal population. However, MVP without MR is a more common abnormality that is associated with only a small risk of endocarditis. NEJM 1982. 307;776. The most common predisposing congenital heart lesions are bicuspid aortic valves, patent ductus arteriosus, ventricular septal defect, coarctation of the aorta, and tetralogy of Fallot. Prevalence of rheumatic valve disease is on the decline.
  • 7. The risk of IE appears to be dependent upon the specific congenital or acquired cardiac lesion. One study, for example, evaluated 2401 patients with congenital heart lesions who were followed prospectively for 40,000 days. Circulation 1993. 87; 121 • The overall incidence of endocarditis was 135 cases/100,000 person years. • The highest rates of endocarditis occurred in patients with aortic stenosis (271)and ventricular septal defects (145 cases/100,000 person yrs). •Among patients with AS, the higher the peak gradient, the higher the risk of developing endocarditis. • The risk of IE with AS was approximately twice as high as with aortic regurgitation. • The lowest rate of endocarditis occurred with pulmonic stenosis. •The risk of IE also appears to be very low in adults with congenital heart disease, inherently normal pulmonic and tricuspid valves, and pulmonary or tricuspid regurgitation due to pulmonary hypertension.
  • 8. Other Risk factorsOther Risk factors A prior history of endocarditis is an important predisposing cause for IE. Recurrent endocarditis occurred in 4.5 percent of one large cohort of non-addicts who survived their initial episode. Ann Int Med 1992 117;567. A number of cases of IE have been reported in patients with HIV infection with some valves have been infected with unusual organisms such as Salmonella and Listeria. It has been suggested that HIV infection is an independent risk factor for IE in injection drug abusers but, this has not been confirmed in other reports. Other less common predisposing factors for IE are pregnancy, arteriovenous fistulas used for hemodialysis, central venous and pulmonary artery catheters, peritoneovenous shunts for the control of intractable ascites and ventriculoatrial shunts for the management of hydrocephalus.
  • 9. Patients with ulcerative lesions of the colon due to carcinoma or inflammatory bowel disease have a poorly understood predilection to develop endocarditis secondary to Streptococcus bovis. IE has also been reported in patients undergoing liver, heart, and heart-lung transplantation.
  • 10. PathogenesisPathogenesis The endothelial lining of the heart and its valves is normally resistant to infection with bacteria and fungi. Although a few highly virulent organisms such as Staphylococcus aureus are capable of infecting normal human heart valves, the initial step in the establishment of a vegetation is injury to the endocardium, followed by focal adherence of platelets and fibrin. These injuries can probably occur naturally in bacteremic humans with congenital or acquired cardiac lesions that induce continuous endocardial trauma via regurgitant flow or high pressure jets of blood through stenotic lesions. The initially sterile platelet-fibrin nidus then becomes infected by microorganisms circulating in the bloodstream, following colonization then microbial growth results in the secondary accumulation of more platelets and fibrin.
  • 11. Microbial adherence is a crucial early event in the pathogenesis of endocarditis. As an example, bacteria that are typically found in patients with endocarditis, such as Staphylococcus aureus, viridans streptococci, enterococci and P. aeruginosa, adhere more avidly to excised canine heart valves in vitro than species which rarely cause endocarditis (such as Escherichia coli). Dextran in the cell wall of gram positive organisms is one factor. Degree of intrinsic binding affinity to fibronectin is important in the virulence of S. aureus species.
  • 12. Components found in damaged endothelium and/or platelet-fibrin aggregates that may mediate adherence include fibrinogen, laminin, and type 4 collagen. Animals treated with aspirin had reduction in the weight of valvular vegetations, vegetation growth, density of bacteria in the kidneys and in vegetations, and a decrease in embolic events compared to controls. This interference with platelet-fibrin aggregates suggests that addition of low dose aspirin can reduce risk of embolization during antibiotic treatment, or risk of IE recurrence. A small clinical study of 9 pts suggested ASA to be protective. J Int Med 1992; 231:543
  • 13. However a more recent randomized trial showed despite promising experimental data, there was no clinical benefit to ASA. 115 pts in Can&US were doubly blinded to receive ASA or placebo. Followed for 4wks for primary outcome of clinical embolism, secondary outcome of CT shown subclinical CVA, hemorrhage or death. No sig difference in embolization. (ASA 28% vs placebo 20%) Non-sig trend for combined major&minor hemorrhage in ASA grp. Total of 70% had CT head done, with significant lesions in 39.5% ASA group vs 29.3% in placebo. Total of 42% had TEE, which showed similar rate of vegetation decrease or valvular regurgitation. JACC 2003; 42:775
  • 14. Physics of VegetationsPhysics of Vegetations If nebulized Serratia marcescens, are injected into an air stream passing through an agar-coated Venturi tube, the highest concentration of bacteria is found in the low pressure area immediately distal to the narrowing. Circulation 1963. 27;18 Vegetations in patients with preexisting valvular lesions are usually located on the atrial surface of incompetent atrioventricular valves, or the ventricular surfaces of incompetent semilunar valves. Patients with ventricular septal defects tend to develop vegetations on the orifice of the defect, on the right ventricular side of the opening, and secondarily on the tricuspid and pulmonic valves. Vegetations may occasionally localize on the chordae tendineae of the anterior leaflet of the mitral valve in patients with aortic insufficiency. Patients with mitral regurgitation may develop vegetations (MacCallum's patch) on the wall of the left atrium where the regurgitant jet strikes the atrial wall and results in endocardial thickening.
  • 15. Clinical SequelaeClinical Sequelae Vegetations often prevent proper valvular leaflet or cusp coaptation, thereby causing valvular incompetence. Congestive heart failure may result from worsening valvular incompetence or leaflet perforation secondary to vegetation growth. Patients with mitral or tricuspid valve vegetations may develop chordal rupture. Infection may also extend into surrounding structures such as the valve ring, the adjacent myocardium, the cardiac conduction system, or the mitral-aortic intravalvular fibrosa. Rarely, cavitation of periaortic abscesses occurs into the adjacent aortic wall, resulting in the formation of a diverticulum or aneurysm. Even more rarely, such aneurysms perforate into surrounding structures, resulting in aortic-atrial or aortic-pericardial fistulae.
  • 16. Etiology (Native Valve)Etiology (Native Valve) Although any bacteria can cause IE, Streptococci, Enterococci and Staphylococci account for the majority of the cases. Streptococci Streptococci account for about 55% of non-IVDA cases. Viridans streptococci account for ~75% of these cases. Most common of the group are Streptococcus mutans, S. mitis, S. Milleri. S. Bovis account for ~20%. Other Streptococci are ~5%. Viridans strep are normal pharynx inhabitants and are generally very susceptible to PCN. 80% of S. Bovis cases occurs in elderly (>60yrs). More than a third have a malignant or pre-malignant colonic lesion.
  • 17. Enterococci Cause about 6% of native valve endocarditis and are normal flora of GI tract, anterior urethra and occasionally the mouth. They are relatively resistant to PCN-G and require the addition of an aminoglycoside to achieve bactericidal effect. More common among males who develop infection around 60 yrs of age. Many have history of GU tract manipulation, trauma or disease. Cystoscopy, Foley catheter, prostatectomy. Caesarian section, abortion, pregnancy.
  • 18. Staphylococci Staph cause about 30% of native valve IE cases, with S. aureus being 5 to 10 times more frequent than S. epidermidis. S. Aureus can rapidly attack normal or damaged valves. It has a fulminant course with death from bacteremia within days, or from heart failure within weeks. Abscesses are common at multiple sites. S. Epidermidis usually infects prosthetic valves.
  • 19. HACEK organisms Haemophilus Actinobacillus Cardiobacterium Eikenella Kingella They are part of the oropharyngeal flora and produce large vegetations with a subacute presentation. They are difficult to isolate from blood and grow slowly in blood culture media. Incubation for 7 to 14 days may be required to detect their growth. This delayed growth makes standard antibiotic susceptibility testing difficult.
  • 20. Other Bacteria Almost any bacteria can be an occasional cause of acute or subacute endocarditis. Streptococcus pneumoniae Neisseria gonorrhoeae Enteric gram –ve bacilli Pseudomonas Salmonella Streptobacillus Serratia marcescens Bacteroides Brucella Mycobacterium Neisseria meningitidis Listeria Legionella Corynebacterium
  • 21. Fungi Rarely cause native valve IE. Subacute course with large vegetations and large emboli. Candida and Aspergillus species can occur in persons with intravascular catheters who are frequently on glucocorticoids, broad spectrum Abx, cytotoxic drugs. Grave prognosis due to the relatively poor activity of antifungal; agents. Other Organisms Rare causes can include Spirochetes, Rickettsiae (Coxiella burnetti), Chlamydiae (C. pneumoniae, C. trachomatis, C. psittaci).
  • 22. Etiology (IVDA)Etiology (IVDA) Frequently occurs in young males with the skin being the most common source of organisms. Contamination of drugs is less common. More than 50% is by S. aureus. ~20% by Streptococci and Enterococci. ~6% Fungi, mainly candida. ~6% gram –ve bacilli, usually Pseudomonas species. Onset is usually acute, with only 20% of addicts having previously damaged valves. Half the cases are involving the tricuspid valve. Aorta is involved in 25% of cases. Mitral valve is involved 20% of the time. Multiple valves less than 5%. In TV endocarditis, murmurs are usually absent and pneumoniae from septic emboli is frequently the presenting picture.
  • 23. Etiology (Prosthetic Valve)Etiology (Prosthetic Valve) With the aging population, prosthetic valve endocarditis now accounts for 10 to 20% of cases. Intravascular sutures, pacemaker wires and Teflon-Silastic tubes are all foci for infection. Most patients are males over 60 and IE occurs in 1-2% in the first year after surgery , and 0.5% a year thereafter. AV prosthesis are more likely to be involved than MV, and infection is usually at the suture line. Early onset (within 60days) is usually as a result of valve contamination or peri-operative bacteremia.
  • 24. Almost half of early onset, and third of late onset endocarditis are due to Staphylococci. S. epidermidis is more frequently involved than S. aureus. Streptococci are the most common cause (40%) of late onset endocarditis, but are rare in early onset.
  • 25. Clinical ManifestationsClinical Manifestations Symptoms generally start within two weeks of precipitating event. With low pathogenicity organism (ie viridans)the onset is usually slow with low fevers. With fulminant disease (ie S. aureus) the onset is rapid with high fevers. Fever is almost always present. Arthralgias, myalgias and low back pain are common. Cardiac murmurs are almost always present, except in acute early IE and in IVDA with TV lesions. Splenomegaly and petechia are usually found in disease of long duration. Petechiae are more common on conjunctiva, palate, buccal mucosa and upper extremities.
  • 26. Splinter hemorrhages are subungual, linear dark red streaks that may appear in IE, but can also result from trauma. Roth’s spots are oval retinal hemorrhages with a clear pale center. But it can occur in connective tissue diseases and sever anemia. Osler’s nodes are small tender nodules in the pads of fingers and toes. Janeway’s lesions are small circular hemorrhagic lesions, that are nodular and occur on palms and soles of feet. Clubbing has been reported in patients with long standing disease. Embolic episodes can occur during or after therapy. Large emboli are generaly fungal.
  • 27. Neurologic manifestations are more common in left sided disease, and in S. aureus infection. Heart failure can occur long after it’s cure. Causes include valvular damage, myocarditis, abscess formation and coronary artery embolization with infarction. Conduction defects occur due to septal invasion. Renal disease exists in most patients due to renal emboli, or immune complex mediated glomerulonephritis.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33. Diagnostic WorkupDiagnostic Workup At least three blood cultures should be obtained from separate sites over a time period ranging from a few hours to one to two days depending upon the severity of illness and urgency of the need for treatment. The additional diagnostic yield of more than three cultures is minimal in patients who have not recently received antimicrobial therapy.
  • 34. A TTE should initially be obtained in patients with native heart valves, while those with prosthetic valves should undergo TEE. Detection of a vegetation is a positive test. However, this procedure has relatively low sensitivity in IE. Thus, a negative study does not preclude the diagnosis TTE should be followed by TEE, which has higher spatial resolution, when there is an intermediate or high suspicion of IE and valvular abnormalities were found on TTE. In general the sensitivity of TTE in detecting vegetations is ~65- 80%. The addition of TEE increases the sensitivity to 95%. In prosthetic valves TTE is has poor diagnostic value. However, TEE carries a 90% sensitivity in this setting. JACC 1991;18
  • 35. A meticulous clinical examination should be performed looking for clinical evidence of small and large emboli with special attention to the fundi, conjunctivae, skin, and digits. In addition, a careful cardiac examination may reveal signs of new regurgitant murmurs and signs of congestive heart failure, and neurologic evaluation may detect evidence of focal neurologic impairment and can be used to document a baseline should such abnormalities appear later.
  • 36. Additional clues to the presence of IE, such as microscopic hematuria, leukocytosis, and evidence of renal impairment should be sought with laboratory testing. All patients with suspected IE should have an electrocardiogram to determine whether there is evidence of heart block or a conduction delay and to establish a baseline should such a complication develop later.
  • 38. Duke ClassificationDuke Classification In 1994 investigators from Duke University modified the von Reyn criteria to include the role of echocardiography in diagnosis. They also expanded the category of predisposing heart conditions to include injection drug use. This was later modified further to include the role of TEE as well as the agent of Q fever (Coxiella brunetti). The Duke classification relies upon major and minor criteria in a manner similar to the Jones criteria for rheumatic fever.
  • 39. Major Criteria •Isolation of causative organism by two separate blood culture’s at least 12hrs apart. •Endocardial involvement evidence by echo. Oscillating mass, prosthetic valve dehiscence, abscess, new regurgitation. Minor criteria •Predisposing lesion or IVDA •Fever >38C •Signs of embolization: Janeway lesion, Intracran hem. •Immunologic phenomena: Glomerulonephritis, Oslers nodes, Rheumatoid factor, Roths spots. •Positive blood culture not meeting major criteria. •Echo finding, but not meeting major criteria.
  • 40. Modified Duke Criteria Definite Infective Endocarditis Pathologic criteria: Microorganisms demonstrated by culture or histology in a vegetation or embolus. Clinical criteria: 2 major or 1 major + 3 minor or 5 minor Possible endocarditis Findings that are suggestive of IE but fall short of definite, but not rejected. Rejected Infective Endocarditis Alternate diagnosis explaining evidence of endocarditis Resolution of syndrome with antibiotic therapy in 4 days or less. No pathologic evidence at surgery with Abx therapy of four days or less. Clin Inf Dis 2000;30
  • 41. Treatment RegimensTreatment Regimens In general the antibiotic regimen chosen is based on agent isolated. The initial microbiologic response to therapy should be assessed by obtaining repeat blood cultures 48 to 72 hours after antibiotics are begun. Most patients with IE generally become afebrile three to five days after treatment is begun with an appropriate antibiotic. Patients with Staphylococcal aureus endocarditis may respond somewhat more slowly, remaining febrile for five to seven days after the institution of therapy. In general, oral regimens should not be used as initial therapy, but may be used in highly selected cases. In right-sided endocarditis of IVDA combination oral therapy with rifampin and ciprofloxacin was as effective as parenteral therapy in patients in whom oral therapy could be closely supervised. Am J Med 1996.101;68
  • 42. Treatment regimen summary Native valve Strep Viridans or Strep Bovis -PCN sensitive PCN-G or Ceftriaxone 4wks If allergic, Vancomycin 4wks Strep Viridans or Strep Bovis - PCN resistant PCN 4wks+Gent 2wk Vancomycin 4wks Enterococcus PCN/AMP + Gent 6wks Vanco + Gent 6wks Staph infection Cefazolin 6wks +/- Gent 5days Vanco 6wks HACEK Organisms Ceftriaxone 4wks
  • 43. Prosthetic valve Streptococcus-PCN sensistive Ceftriaxone 6wks + Gent 2wks Vanco 6wks Streptococcus-PCN resistant Strep Vanco 6wks Enterococci PCN or Amp 6wks + Gent 6wks Vanco+Gent 6wks Methicllin Susceptible Staph Nafcillin 6wks + Gent 2wks + Rifampin 6wks MRSA Vanco 8wks + Gent 2wks + rifampin 8wks HACEK Ceftriaxone 6wks Diptheroides PCN +Gent 6wks Vanco 6wks
  • 44. Surgical InterventionSurgical Intervention The outcome of surgery is better when the infection is partially treated or healed. So, patients with severe valve dysfunction who respond to antibiotic therapy and who manifest evidence of only mild and nonprogressive heart failure should complete a full course of antibiotics before surgery is undertaken to minimize morbidity and mortality. However, surgery should not be delayed to complete antimicrobial therapy in patients with progressive heart failure or evidence of other complications. Two general classes of valves exist, bioprosthetic and mechanical.
  • 46. Class I indication for native valve surgery Acute AR or MR with heart failure Acute AR with tachycardia or early closure or MV on echo Fungal endocarditis Aortic or annular abscess, or aortic aneurysm Valve dysfunction or infection after 10 days of Abx therapy Class II indication for native valve surgery Recurrent emboli after >24hrs Abx therapy Mobile vegetations >10mm
  • 47. Recommendation for Bioprosthesis placement Pt cannot take warfarin >65yrs who do not need warfarin for another cause Recommendation for mechanical valve placement Expected long life span Mechanical valve in another position Pt with renal failure or hypercalcemia Require warfarin for another cause
  • 48.
  • 49. Non-bacterial ThromboticNon-bacterial Thrombotic EndocarditisEndocarditis Combination of endothelial injury and hypercoagulable state can lead to platelet-thrombin deposition. These deposits are found on the atrial side of MV & TV, and the ventricular side of AV & PV; similar to location of infective vegetations. Most common associated syndrome with this condition is the anti- phospholipid syndrome. The atypical verroucous Libman-Sacks vegetations are usually difficult to see on TTE. They usually accumulate on the distal tip of the MV.
  • 50. Metastatic tumours can also involve cardiac valves and produce lesions similar to IE. These marantic endocarditis lesions occur more frequently in Hodgkin and adenocarcinoma of the lung, stomach and colon. All non bacterial thrombotic lesion can become infected if exposed to bacteremia.
  • 51. Antibiotic ProphylaxisAntibiotic Prophylaxis Bacteria colonize and adhere to platelet-fibrin aggregates during bacteremia. Although many bacteria enter the blood stream, only those suited to adhere to surfaces can become infective. Certain predisposing valvular lesions are also required to increase your risk of colonization. This has led to identifying patients at risk during surgical procedures and the use of prophylactic antibiotics.
  • 52. Prophylaxis recommended Dental procedures, including scaling and cleaning Tonsillectomy & adenoidectomy Surgery involving GI or upper respiratory mucosa Esophageal varices sclerotherapy ERCP Cholecystectomy Cystoscopy, urethral dilatation GU surgery Incision and drainage of infected tissue
  • 53. Prophylaxis not recommended Dental procedures not likely to produce bleeding, i.e. filling above gum line, orthodontic adjustments. Endotracheal intubation TEE Flexible bronchoscope +/- biopsy Angiography +/- PTCA Pacemaker implantation GI Endoscopy +/- biopsy C-section In absence of infection: uncomplicated vaginal delivery, therapeutic abortion, IUD, laparoscopy, circumcision.
  • 54. High Risk Patients Prosthetic valve Prior IE Cyanotic congenital heart disease PDA AR AS MR MS + MR VSD Coarctation of Ao Surgically constructed systemic-pulmonary shunts Surgically corrected cardiac lesion with residual hemodynamic abn or prosthesis.
  • 55. Intermediate Risk Patients MV prolapse or thickening with murmur Pure MS TV disease PS Asymmetrical septal hypertrophy Bicuspid AV with minimal hemodynamic changes Ao sclerosis with minimal hemodynamic changes Surgically repaired intracardiac lesions, less than six mos postop, with minimal hemodynamic changes.
  • 56. Low Risk Patients MV prolapse without murmur Isolated secundum ASD Implanted devices CABG Prior Kawasaki’s or Rheumatic disease without valvular dysfunction
  • 57. Antibiotic Prophylaxis SummaryAntibiotic Prophylaxis Summary GI/GU regimen High risk Amp 2g & Gent 1.5mg/kg. Mod risk Amox 2g or Amp. PCN allergy = Substitute Vanco 1g Oral/Esoph/Resp regimen Amox PO or Amp IV PCN allergy = Substitute Clinda 600mg PO/IV Cefazolin 1g Azith/Clarith PO 500mg Abx should be given prior to procedure, 1hr for oral 1/2hr for parenteral
  • 58.
  • 59.
  • 61.
  • 62. UTD Abx TablesUTD Abx Tables
  • 63.
  • 64.
  • 65.
  • 66.
  • 67.
  • 68.
  • 69.
  • 70. UTD Surgery tablesUTD Surgery tables